Quantitative analysis for Legend Biotech Corporation (LEGN) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Sell (42.0) (grade D). 30 signals analyzed (25 differentiated alt-data).
LEGN stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $23.74 | $22.70 | $22.77 |
| 2026-05-11 | $28.59 | $25.17 | $25.58 |
| 2026-05-21 | $28.69 | $27.39 | $27.99 |
| 2026-06-03 | $37.50 | $34.35 | $35.98 |
| 2026-06-15 | $36.18 | $34.81 | $35.48 |
| 2026-06-26 | $29.32 | $27.89 | $28.69 |
| 2026-07-09 | $28.13 | $27.31 | $27.38 |
| 2026-07-21 | $23.88 | $23.02 | $23.54 |
| 2026-07-31 | $19.00 | $18.33 | $18.55 |
| 2026-08-12 | $21.61 | $20.45 | $20.65 |
| 2026-08-24 | $22.27 | $20.79 | $20.94 |
| 2026-09-03 | $22.05 | $21.52 | $21.75 |
How Legend Biotech Corporation stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| STVN | Stevanato Group S.p.A. | $4.8B | — |
| BLTE | Belite Bio, Inc | $5.7B | — |
| BLCO | Bausch + Lomb Corporation | $5.8B | — |
| MANE | Veradermics, Incorporated | $4.4B | — |
View all Health Care stocks by valuation and signals →
Legend Biotech Corporation (LEGN) scores Sell (42.0), and the composite conceals a 45-point disagreement between its dimensions. It is strongest on analyst consensus at 79, and weakest on technicals at 34. A stock can carry analyst consensus that high while technicals sits at 34; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| analyst consensus | 79 |
| technicals | 34 |
StoQuant analyzes 30 signals (25 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Legend Biotech Corporation (LEGN): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/LEGN"><img src="https://stoquant.com/badge/LEGN.svg" alt="Legend Biotech Corporation (LEGN) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.